Late-onset riboflavin–responsive myopathy with combined multiple acyl coenzyme a dehydrogenase and respiratory chain deficiency

C. Antozzi, B. Garavaglia, M. Mora, M. Rimoldi, L. Morandi, E. Ursino, Stefano Di Donato

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

We studied the effect of riboflavin treatment on the clinical status and on the activities of β-oxidation and respiratory chain enzymes in a 69-year-old patient with late-onset myopathy. Before treatment, she was very weak and wasted in the limbs and trunk muscles; also, she could not walk or attend to daily activities. Marked lipid storage was present in the muscle biopsy. The activities of short-chain acyl coenzyme A (acyl-CoA) dehydrogenase (SCAD), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD) in isolated muscle mitochondria were reduced to less than 10% of control values. This defect in fatty acid oxidation was associated with a marked deficiency of two flavin-dependent respiratory chain complexes: complex I activity was 20% and complex II activity was 25% of control values. By contrast, the activities of the nonflavin-dependent complex III and complex IV were normal. Western blot analysis of the patient's muscle mitochondrial extracts with antibodies raised against purified SCAD, MCAD, and the α-and β-subunits of the electron transfer flavoprotein (ETF) showed absence of SCAD cross-reacting material (CRM), markedly decreased MCAD-CRM, and normal amounts of both α- and β-ETF-CRM. After riboflavin treatment, the patient's clinical status dramatically improved and morphologic changes in muscle disappeared. SCAD activity increased to 55% of control values, whereas MCAD, LCAD, and complex I and complex II activities normalized. SCAD and MCAD immunoreactivity was restored to normal. On the basis of our experience and the data in the literature, we concluded that some lipid storage myopathies can show dramatic response to riboflavin.

Original languageEnglish
Pages (from-to)2153-2158
Number of pages6
JournalNeurology
Volume44
Issue number11
Publication statusPublished - 1994

Fingerprint

Acyl-CoA Dehydrogenase
Coenzymes
Muscular Diseases
Electron Transport
Oxidoreductases
Riboflavin
Electron-Transferring Flavoproteins
Long-Chain Acyl-CoA Dehydrogenase
Muscles
Muscle Mitochondrion
Electron Transport Complex III
Onset
Fatty Acids
Therapeutics
Extremities
Western Blotting
Lipids
Biopsy
Antibodies
Enzymes

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Late-onset riboflavin–responsive myopathy with combined multiple acyl coenzyme a dehydrogenase and respiratory chain deficiency. / Antozzi, C.; Garavaglia, B.; Mora, M.; Rimoldi, M.; Morandi, L.; Ursino, E.; Di Donato, Stefano.

In: Neurology, Vol. 44, No. 11, 1994, p. 2153-2158.

Research output: Contribution to journalArticle

@article{c4fea50c50e24ba0b03bfd19efda5d7c,
title = "Late-onset riboflavin–responsive myopathy with combined multiple acyl coenzyme a dehydrogenase and respiratory chain deficiency",
abstract = "We studied the effect of riboflavin treatment on the clinical status and on the activities of β-oxidation and respiratory chain enzymes in a 69-year-old patient with late-onset myopathy. Before treatment, she was very weak and wasted in the limbs and trunk muscles; also, she could not walk or attend to daily activities. Marked lipid storage was present in the muscle biopsy. The activities of short-chain acyl coenzyme A (acyl-CoA) dehydrogenase (SCAD), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD) in isolated muscle mitochondria were reduced to less than 10{\%} of control values. This defect in fatty acid oxidation was associated with a marked deficiency of two flavin-dependent respiratory chain complexes: complex I activity was 20{\%} and complex II activity was 25{\%} of control values. By contrast, the activities of the nonflavin-dependent complex III and complex IV were normal. Western blot analysis of the patient's muscle mitochondrial extracts with antibodies raised against purified SCAD, MCAD, and the α-and β-subunits of the electron transfer flavoprotein (ETF) showed absence of SCAD cross-reacting material (CRM), markedly decreased MCAD-CRM, and normal amounts of both α- and β-ETF-CRM. After riboflavin treatment, the patient's clinical status dramatically improved and morphologic changes in muscle disappeared. SCAD activity increased to 55{\%} of control values, whereas MCAD, LCAD, and complex I and complex II activities normalized. SCAD and MCAD immunoreactivity was restored to normal. On the basis of our experience and the data in the literature, we concluded that some lipid storage myopathies can show dramatic response to riboflavin.",
author = "C. Antozzi and B. Garavaglia and M. Mora and M. Rimoldi and L. Morandi and E. Ursino and {Di Donato}, Stefano",
year = "1994",
language = "English",
volume = "44",
pages = "2153--2158",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Late-onset riboflavin–responsive myopathy with combined multiple acyl coenzyme a dehydrogenase and respiratory chain deficiency

AU - Antozzi, C.

AU - Garavaglia, B.

AU - Mora, M.

AU - Rimoldi, M.

AU - Morandi, L.

AU - Ursino, E.

AU - Di Donato, Stefano

PY - 1994

Y1 - 1994

N2 - We studied the effect of riboflavin treatment on the clinical status and on the activities of β-oxidation and respiratory chain enzymes in a 69-year-old patient with late-onset myopathy. Before treatment, she was very weak and wasted in the limbs and trunk muscles; also, she could not walk or attend to daily activities. Marked lipid storage was present in the muscle biopsy. The activities of short-chain acyl coenzyme A (acyl-CoA) dehydrogenase (SCAD), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD) in isolated muscle mitochondria were reduced to less than 10% of control values. This defect in fatty acid oxidation was associated with a marked deficiency of two flavin-dependent respiratory chain complexes: complex I activity was 20% and complex II activity was 25% of control values. By contrast, the activities of the nonflavin-dependent complex III and complex IV were normal. Western blot analysis of the patient's muscle mitochondrial extracts with antibodies raised against purified SCAD, MCAD, and the α-and β-subunits of the electron transfer flavoprotein (ETF) showed absence of SCAD cross-reacting material (CRM), markedly decreased MCAD-CRM, and normal amounts of both α- and β-ETF-CRM. After riboflavin treatment, the patient's clinical status dramatically improved and morphologic changes in muscle disappeared. SCAD activity increased to 55% of control values, whereas MCAD, LCAD, and complex I and complex II activities normalized. SCAD and MCAD immunoreactivity was restored to normal. On the basis of our experience and the data in the literature, we concluded that some lipid storage myopathies can show dramatic response to riboflavin.

AB - We studied the effect of riboflavin treatment on the clinical status and on the activities of β-oxidation and respiratory chain enzymes in a 69-year-old patient with late-onset myopathy. Before treatment, she was very weak and wasted in the limbs and trunk muscles; also, she could not walk or attend to daily activities. Marked lipid storage was present in the muscle biopsy. The activities of short-chain acyl coenzyme A (acyl-CoA) dehydrogenase (SCAD), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD) in isolated muscle mitochondria were reduced to less than 10% of control values. This defect in fatty acid oxidation was associated with a marked deficiency of two flavin-dependent respiratory chain complexes: complex I activity was 20% and complex II activity was 25% of control values. By contrast, the activities of the nonflavin-dependent complex III and complex IV were normal. Western blot analysis of the patient's muscle mitochondrial extracts with antibodies raised against purified SCAD, MCAD, and the α-and β-subunits of the electron transfer flavoprotein (ETF) showed absence of SCAD cross-reacting material (CRM), markedly decreased MCAD-CRM, and normal amounts of both α- and β-ETF-CRM. After riboflavin treatment, the patient's clinical status dramatically improved and morphologic changes in muscle disappeared. SCAD activity increased to 55% of control values, whereas MCAD, LCAD, and complex I and complex II activities normalized. SCAD and MCAD immunoreactivity was restored to normal. On the basis of our experience and the data in the literature, we concluded that some lipid storage myopathies can show dramatic response to riboflavin.

UR - http://www.scopus.com/inward/record.url?scp=0027948406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027948406&partnerID=8YFLogxK

M3 - Article

C2 - 7969976

AN - SCOPUS:0027948406

VL - 44

SP - 2153

EP - 2158

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -